Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesEZZ Life Science Holdings Ltd

EZZ Life Science Holdings Ltd

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.3 AUD -0.01 ( 1.64%)
Last update at 2026-11-06T05:10:00Z
VOLUME
3024
Market Cap
14.36M

Momentum Score

…

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.30
Low
0.30
High
52 Week Price Range
0.29
Low
2.58
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

EZZ Life Science Holdings Ltd (ASX: EZZ) is an Australian-listed company that develops, markets and distributes nutraceutical and health-wellness products. Long-term growth drivers include ageing populations and rising preventive-health demand, together with potential gains from expanding distribution channels and broadening the product portfolio that may support revenue diversification.

Important risks include regulatory and compliance exposure in the dietary-supplement sector, strong competitive pressure, execution and scaling risk for distribution and new products, and potential liquidity or financing constraints common to small-cap consumer-health companies.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.30
Dividend Yield
-
Revenue TTM
46.28M
Revenue Per Share
0.98
Gross Profit TTM
31.27M
Debt / Equity
0.02
ROE
-20.25%
Net Debt
-9.25M
ROCE
175.99%
Diluted EPS TTM
-0.11

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.41M 10.59M 9.96M 4.90M 1.78M
Net income -5.32M 6.73M 6.96M 3.63M 1.31M
Selling general administrative - 3.60M 1.26M 1.15M 0.90M
Selling and marketing expenses - 32.27M 37.23M 20.56M 2.97M
Gross profit 25.77M 49.72M 50.95M 27.20M 7.51M
Reconciled depreciation - 0.51M 0.39M 0.18M 0.12M
Ebit 43.40M 10.59M 9.98M 4.91M 1.78M
Ebitda 43.88M 11.10M 10.38M 5.09M 1.90M
Depreciation and amortization 0.49M 0.51M 0.39M 0.18M 0.12M
Operating income 43.40M 9.93M 9.72M 4.62M 1.64M
Other operating expenses 52.89M 56.94M 56.73M 32.53M 13.38M
Interest expense 0.02M 0.03M 0.02M 0.01M 0.00M
Tax provision - 3.86M 2.99M 1.27M 0.47M
Interest income - 0.42M 0.20M 0.24M 0.00M
Net interest income - 0.39M 0.17M 0.03M -0.00M
Income tax expense -1.09M 3.86M 2.99M 1.27M 0.47M
Total revenue 46.28M 66.87M 66.44M 37.14M 15.02M
Total operating expenses 32.38M 39.79M 41.23M 22.59M 5.87M
Cost of revenue 20.51M 17.15M 15.50M 9.94M 7.51M
Total other income expense net -49.81M 0.66M 0.24M 0.29M 0.14M
Net income from continuing ops - 6.73M 6.96M 3.63M 1.31M
Net income applicable to common shares - 6.73M 6.96M 3.63M 1.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 27.64M 33.96M 25.55M 17.64M 14.27M
Intangible assets 0.03M 0.03M - 0.02M 0.02M
Other current assets 7.25M 0.89M 1.81M 0.94M 0.90M
Total liab 3.15M 5.87M 4.23M 3.06M 2.88M
Total stockholder equity 24.49M 28.09M 21.32M 14.58M 11.39M
Other current liab 0.58M - 0.04M 0.36M 0.32M
Common stock 11.40M - 6.52M 6.00M 5.82M
Capital stock - 8.74M - 6.00M 5.82M
Retained earnings 13.07M 19.32M 14.79M 8.58M 5.56M
Other liab - - - - 0.06M
Other assets - - - 0.01M 0.13M
Cash 9.72M 20.85M 19.02M 13.83M 10.46M
Total current liabilities 2.98M 5.73M 4.18M 2.93M 2.82M
Current deferred revenue - - 1.20M - -
Net debt -9.25M - -18.90M - -10.36M
Short term debt 0.35M - 0.12M 0.00M 0.10M
Short long term debt total 0.48M - 0.12M - 0.10M
Other stockholder equity - - 0.00M 0.00M -
Property plant equipment - - - 0.60M 0.15M
Total current assets 25.95M 33.04M 24.91M 17.01M 13.97M
Net tangible assets - - - 14.56M 11.37M
Net receivables 4.96M 4.47M 2.67M 1.39M 2.29M
Inventory 4.02M 2.43M 1.40M 0.85M 0.31M
Accounts payable 2.05M 3.46M 2.82M 2.14M 2.39M
Accumulated other comprehensive income 0.02M - 0.02M - -
Non currrent assets other - - 0.02M - -
Non current assets total 1.69M 0.92M 0.64M 0.63M 0.29M
Capital lease obligations - 0.30M - 0.48M 0.10M
Long term debt total - - - 0.12M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.55M -0.44M -0.10M -0.01M
Change to liabilities - - - -0.16M 0.88M
Total cashflows from investing activities -0.65M -0.55M -0.44M -0.10M -0.01M
Net borrowings - - - -0.16M -0.10M
Total cash from financing activities -1.26M -2.17M -0.58M -0.76M -0.28M
Change to operating activities - - - -0.02M -0.48M
Net income -5.32M 6.73M 6.96M 3.63M 1.31M
Change in cash -11.13M 1.83M 5.19M 3.37M 1.61M
Begin period cash flow 20.85M 19.02M 13.83M 10.46M 8.85M
End period cash flow 9.72M 20.85M 19.02M 13.83M 10.46M
Total cash from operating activities -8.76M 4.35M 6.14M 4.01M 1.90M
Issuance of capital stock - - 0.85M - -
Depreciation 0.49M - 0.39M 0.18M 0.12M
Other cashflows from investing activities -0.62M -0.30M -0.03M - -0.01M
Dividends paid 0.90M 1.82M 1.08M 0.60M 0.17M
Change to inventory -1.59M -1.03M -0.55M -0.53M -0.04M
Change to account receivables -0.40M -1.84M -1.29M 0.91M -0.11M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities -0.36M 0.00M -0.35M -0.16M -0.10M
Change to netincome - - - -0.04M 0.16M
Capital expenditures 0.03M 0.26M 0.41M 0.10M 0.01M
Change in working capital -7.05M -4.58M -1.16M 0.24M 0.31M
Stock based compensation - - 0.02M 0.18M 0.16M
Other non cash items 3.12M 8.93M -0.06M 0.17M -0.24M
Free cash flow -8.79M 4.09M 5.73M 3.91M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EZZ
EZZ Life Science Holdings Ltd		 -0.01
1.64%		 0.30 - - 0.31 0.59 0.11 0.78
CSL
CSL Ltd		 -0.36
0.18%		 202.04 - 22.57 6.15 4.48 4.82 10.06
TLX
TELIX Pharmaceuticals Ltd		 -0.41
2.91%		 13.67 93.87 166.67 5.37 6.37 3.85 47.29
NEU
Neuren Pharmaceuticals Ltd		 -
-%		 23.24 154.93 36.36 42.38 7.52 31.95 160.40
MSB
Mesoblast Ltd		 -0.14
6.45%		 2.03 - 454.55 23.43 3.36 18.28 -9.86

Profile*

EZZ Life Science Holdings Ltd

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, Australia, 2141

61 2 9160 2305

https://ezzlife.com.au

Name Title Year Born
Mr. Mark Qin Co-founder, COO, Interim CEO & Exec. Director NA
Anthony Guarna Chief Financial Officer NA
Ms. Natalie Climo L.L.B. Company Sec. NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…